| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.76▼ | 3.77▼ | 3.76▼ | 3.76▼ | 3.48▲ |
| MA10 | 3.78▼ | 3.77▼ | 3.78▼ | 3.72▲ | 3.21▲ |
| MA20 | 3.79▼ | 3.78▼ | 3.78▼ | 3.43▲ | 3.62▲ |
| MA50 | 3.78▼ | 3.78▼ | 3.76▼ | 3.18▲ | 5.05▼ |
| MA100 | 3.79▼ | 3.76▼ | 3.55▲ | 3.63▲ | 8.51▼ |
| MA200 | 3.78▼ | 3.52▲ | 3.36▲ | 4.69▼ | 29.63▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.008▼ | -0.005▼ | -0.009▼ | 0.034▲ | 0.169▲ |
| RSI | 22.008▼ | 35.792▼ | 40.632▼ | 66.597▲ | 43.305▼ |
| STOCH | 2.083▼ | 33.618 | 21.235 | 85.534▲ | 65.553 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -12.500▲ | -46.243 |
| CCI | -227.350▼ | -135.632▼ | -196.069▼ | 58.573 | 108.820▲ |
|
Friday, October 30, 2026 01:30 AM
Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to ...
|
|
Thursday, October 29, 2026 02:00 AM
Keynote/plenary session and late-breaking poster presentation highlight additional data from Phase 2 AMPLIFY-7P trial of camupepimut (ELI-002 7P) ...
|
|
Thursday, October 29, 2026 02:00 AM
Immunocore will present Phase 1 data for brenetafusp plus KIMMTRAK® (tebentafusp-tebn) in metastatic uveal melanoma, during a late-breaking oral ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/10/26 | 3.84 | 3.84 | 3.72 | 3.73 | 2,890,097 |
| 29/10/26 | 3.79 | 3.83 | 3.765 | 3.82 | 3,705,859 |
| 28/10/26 | 3.75 | 3.80 | 3.715 | 3.79 | 1,925,690 |
| 27/10/26 | 3.73 | 3.80 | 3.72 | 3.76 | 1,469,456 |
| 26/10/26 | 3.73 | 3.80 | 3.71 | 3.72 | 2,624,878 |
| 23/10/26 | 3.78 | 3.78 | 3.685 | 3.74 | 3,301,218 |
| 22/10/26 | 3.74 | 3.835 | 3.71 | 3.74 | 3,890,777 |
| 21/10/26 | 3.64 | 3.73 | 3.62 | 3.71 | 1,641,391 |
| 20/10/26 | 3.59 | 3.69 | 3.57 | 3.64 | 2,006,380 |
| 19/10/26 | 3.44 | 3.60 | 3.39 | 3.56 | 3,944,770 |
|
|
||||
|
|
||||
|
|